MILLIPLEX^® Rat Kidney Toxicity Panel

KIM-1, Clusterin, and GSTα are sensitive indicators of tubular injury and cellular stress. IP-10/CXCL10 and TIMP-1 reflect renal inflammation and tissue remodeling. OPN and VEGF-A are involved in fibrosis and vascular responses. Together, these biomarkers offer a comprehensive view of kidney toxicity and repair mechanisms in rat models.

MILLIPLEX^® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 7 analytes in rat urine samples.

Analytes Included: Clusterin, GSTα, IP-10/CXCL10, KIM-1, Osteopontin (OPN), TIMP-1, VEGF-A Note: GSTα is in a competitive assay format.

Assay Characteristics: Refer to the assay protocol for details on cross-reactivity, sensitivity, precision, and accuracy.

Features:

• Multiplex detection of 7 kidney injury biomarkers in one assay
• Magnetic bead-based format for efficient and reproducible processing
• Compatible with urine samples
• High sensitivity for early detection of renal damage

Benefits:

• Conserves sample volume and reagents through multiplexing
• Improves data quality and reproducibility with magnetic bead format
• Enables early detection and monitoring of kidney injury

Luminex is a registered trademark of Luminex Corporation

MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

xMAP is a registered trademark of Luminex Corp

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.